Publications

Publications 2025

1. Bjørkekjær HJ, Bruni C, Broch K, Brunborg C, Carreira PE, Airò P, Simeón-Aznar CP, Truchetet ME, Giollo A, Balbir-Gurman A, Martin M, Denton CP, Gabrielli A, Del Galdo F, Vonk MC, Fretheim H, Bitter H, Midtvedt Ø, Andreassen A, Høie S, Tanaka Y, Riemekasten G, Müller-Ladner U, Matucci-Cerinic M, Castellví I et al. (2025)
   A comparative analysis of risk stratification tools in systemic sclerosis-associated pulmonary arterial hypertension: a EUSTAR analysis
   Rheumatology (Oxford) (in press)
   DOI 10.1093/rheumatology/keaf053, PubMed 39878955
2. Ravnestad H, Murbræch K, Gjønnæss E, Andersen R, Moe N, Birkeland S, Svalebjørg M, Lingaas PS, Gude E, Gullestad L, Kvitting JP, Broch K, Andreassen AK (2025)
   Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
   Heart, 111 (3), 125-132
   DOI 10.1136/heartjnl-2024-324243, PubMed 39467613
3. Svedlund Eriksson E, Lantero Rodriguez M, Halvorsen B, Johansson I, Mårtensson AKF, Wilhelmson AS, Huse C, Ueland T, Aukrust P, Broch K, Gullestad L, Amundsen BH, Andersen GØ, Karlsson MCI, Hagberg Thulin M, Camponeschi A, Trompet D, Hammarsten O, Redfors B, Borén J, Omerovic E, Levin MC, Chagin AS, Dahl TB, Tivesten Å (2025)
   Testosterone exacerbates neutrophilia and cardiac injury in myocardial infarction via actions in bone marrow
   Nat Commun, 16 (1), 1142
   DOI 10.1038/s41467-025-56217-x, PubMed 39910039

Publications 2024

1. Andresen K, Klæboe LG, Lie ØH, Broch K, Kvaslerud AB, Bosse G, Hopp E, de Lange C, Haugaa KH, Edvardsen T (2024)
   No adverse association between exercise exposure and diffuse myocardial fibrosis in male endurance athletes
   Sci Rep, 14 (1), 6581
   DOI 10.1038/s41598-024-57233-5, PubMed 38503845
2. Bollano E, Andreassen AK, Eiskjaer H, Gustafsson F, Rådegran G, Gude E, Gullestad L, Broch K, Halden TAS, Karason K, Bartfay SE, Bergh N, SCHEDULE (Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance) investigators (2024)
   Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial
   J Heart Lung Transplant, 43 (12), 1948-1959
   DOI 10.1016/j.healun.2024.07.002, PubMed 39038562
3. Bratseth V, Nendl A, Raju SC, Holm K, Broch K, Hov JR, Seljeflot I, Trøseid M, Awoyemi A (2024)
   Gut dysbiosis and neutrophil extracellular traps in chronic heart failure
   Int J Cardiol, 419, 132689
   DOI 10.1016/j.ijcard.2024.132689, PubMed 39489348
4. Broch K, Lemström KB, Gustafsson F, Eiskjær H, Karason K, Gjesdal G, Fagerland MW, Pentikainen M, Lommi J, Gude E, Andreassen AK, Clemmensen TS, Christiansen EH, Bjørkelund E, Berg ES, Arora S, Gullestad L (2024)
   Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant Recipients
   JACC Heart Fail, 12 (10), 1677-1688
   DOI 10.1016/j.jchf.2024.04.026, PubMed 38934968
5. De Bortoli A, Nordøy I, Connelly JP, Viermyr HK, Bjerkreim RH, Broch K, Olsen PAS, Gude E, Fevang B, Jørgensen SF, Trøseid M, Steen T, Aukrust P, Andreassen AK, Skarpengland T (2024)
   Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohort
   Int J Cardiol, 400, 131809
   DOI 10.1016/j.ijcard.2024.131809, PubMed 38272129
6. Grov I, Authen AR, Arora S, Bergh N, Rolid K, Gustafsson F, Eiskjær H, Rådegran G, Gude E, Andreassen AK, Halden T, Broch K, Gullestad L, SCHEDULE investigators (2024)
   The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10-12 Years After Heart Transplantation: The Results of a Randomized Controlled Trial (SCHEDULE Trial)
   Clin Transplant, 38 (11), e70028
   DOI 10.1111/ctr.70028, PubMed 39575520
7. Holme FA, Huse C, Kong XY, Broch K, Gullestad L, Anstensrud AK, Andersen GØ, Amundsen BH, Kleveland O, Quiles-Jimenez A, Holm S, Aukrust P, Alseth I, Halvorsen B, Dahl TB (2024)
   Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction
   Int J Mol Sci, 25 (16)
   DOI 10.3390/ijms25169014, PubMed 39201700
8. Holt MF, Holmen S, Rolid K, Englund KVB, Østby CM, Ravnestad H, Andreassen AK, Gullestad L, Gude E, Broch K (2024)
   The association between body mass index, exercise capacity, and health-related quality of life in heart transplant recipients
   Front Transplant, 3, 1379695
   DOI 10.3389/frtra.2024.1379695, PubMed 38993775
9. Hunt TEF, Traaen GM, Aakerøy L, Massey RJ, Bendz C, Øverland B, Akre H, Steinshamn S, Loennechen JP, Broch K, Helle-Valle T, Lie ØH, Anstensrud AK, Haugaa KH, Gullestad L, Anfinsen OG, Aakhus S (2024)
   Cardiac remodelling in patients with atrial fibrillation and obstructive sleep apnoea
   Open Heart, 11 (2)
   DOI 10.1136/openhrt-2024-002718, PubMed 39477342
10. Khan FH, Zhao D, Ha JW, Nagueh SF, Voigt JU, Klein AL, Gude E, Broch K, Chan N, Quill GM, Doughty RN, Young A, Seo JW, García-Izquierdo E, Moñivas-Palomero V, Mingo-Santos S, Wang TKM, Bezy S, Ohte N, Skulstad H, Beladan CC, Popescu BA, Kikuchi S, Panis V, Donal E et al. (2024)
    Evaluation of left ventricular filling pressure by echocardiography in patients with atrial fibrillation
    Echo Res Pract, 11 (1), 14
    DOI 10.1186/s44156-024-00048-x, PubMed 38825684
11. Kindberg KM, Broch K, Andersen GØ, Anstensrud AK, Åkra S, Woxholt S, Tøllefsen IM, Ueland T, Amundsen BH, Kløw NE, Halvorsen B, Dahl TB, Huse C, Murphy SL, Damås JK, Opdahl A, Wiseth R, Gullestad L, Aukrust P, Santos-Gallego C, Seljeflot I, Stokke MK, Helseth R (2024)
    Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct Size
    JACC Adv, 3 (9), 101193
    DOI 10.1016/j.jacadv.2024.101193, PubMed 39247678
12. Myhre PL, Kleiven Ø, Berge K, Grundtvig M, Gullestad L, Ørn S (2024)
    Changes in 6-min walk test is an independent predictor of death in chronic heart failure with reduced ejection fraction
    Eur J Heart Fail, 26 (12), 2608-2615
    DOI 10.1002/ejhf.3391, PubMed 39058228
13. Raju SC, Molinaro A, Awoyemi A, Jørgensen SF, Braadland PR, Nendl A, Seljeflot I, Ueland PM, McCann A, Aukrust P, Vestad B, Mayerhofer C, Broch K, Gullestad L, Lappegård KT, Halvorsen B, Kristiansen K, Hov JR, Trøseid M (2024)
    Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity
    Genome Med, 16 (1), 27
    DOI 10.1186/s13073-024-01296-6, PubMed 38331891
14. Ribic D, Remme EW, Smiseth OA, Massey RJ, Eek CH, Kvitting JP, Gullestad L, Broch K, Russell K (2024)
    Non-invasive myocardial work in aortic stenosis: validation and improvement in left ventricular pressure estimation
    Eur Heart J Cardiovasc Imaging, 25 (2), 201-212
    DOI 10.1093/ehjci/jead227, PubMed 37672652
15. Ruud M, Frisk M, Melleby AO, Norseng PA, Mohamed BA, Li J, Aronsen JM, Setterberg IE, Jakubiczka J, van Hout I, Coffey S, Shen X, Nygård S, Lunde IG, Tønnessen T, Jones PP, Sjaastad I, Gullestad L, Toischer K, Dahl CP, Christensen G, Louch WE (2024)
    Regulation of cardiomyocyte t-tubule structure by preload and afterload: Roles in cardiac compensation and decompensation
    J Physiol, 602 (18), 4487-4510
    DOI 10.1113/JP284566, PubMed 38686538
16. Svenningsen A, Söderström S, Bucher Sandbakk S, Gullestad L, Bønaa KH, Wisløff U, Hollekim-Strand SM (2024)
    Mind the intention-behavior gap: a qualitative study of post-myocardial infarction patients' beliefs and experiences with long-term supervised and self-monitored physical exercise
    BMC Sports Sci Med Rehabil, 16 (1), 204
    DOI 10.1186/s13102-024-00987-2, PubMed 39334432
17. Woxholt S, Ueland T, Aukrust P, Anstensrud AK, Broch K, Tøllefsen IM, Seljeflot I, Halvorsen B, Dahl TB, Huse C, Andersen GØ, Gullestad L, Wiseth R, Damås JK, Kleveland O (2024)
    Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI
    Int J Cardiol, 418, 132613
    DOI 10.1016/j.ijcard.2024.132613, PubMed 39374793

Publications 2023

1. Arora S, Zimmermann FM, Solberg OG, Nytrøen K, Aaberge L, Okada K, Ahn JM, Honda Y, Khush KK, Angeras O, Karason K, Gullestad L, Fearon WF (2023)
   Prognostic value of intravascular ultrasound early after heart transplantation
   Eur Heart J, 44 (48), 5160-5162
   DOI 10.1093/eurheartj/ehad648, PubMed 37850514
2. Berg ES, Tegn NK, Abdelnoor M, Røysland K, Ryalen PC, Aaberge L, Eek C, Øie E, Juliebø V, Gjertsen E, Ranhoff AH, Gullestad L, Nordstrand N, Bendz B, After Eighty Study Investigators (2023)
   Long-Term Outcomes of Invasive vs Conservative Strategies for Older Patients With Non-ST-Segment Elevation Acute Coronary Syndromes
   J Am Coll Cardiol, 82 (21), 2021-2030
   DOI 10.1016/j.jacc.2023.09.809, PubMed 37968019
3. Berg R, Clemmensen TS, Petersen MS, Mogensen LJH, Christiansen M, Rolid K, Nytrøen K, Møller BK, Gullestad L, Eiskjær H, Koefoed-Nielsen P (2023)
   Kinetics of Torque Teno virus in heart transplant patients
   Hum Immunol, 84 (12), 110720
   DOI 10.1016/j.humimm.2023.110720, PubMed 37867096
4. Birkeland KI, Meling S, Alsnes IV, Svensson E, Gullestad L, Jenssen TG (2023)
   New international recommendations for type 2 diabetes - consequences for treatment practice in Norway?
   Tidsskr Nor Laegeforen, 143 (3)
   DOI 10.4045/tidsskr.22.0672, PubMed 36811420
5. Christensen AH, Wyller VBB, Nygaard S, Rolid K, Nytrøen K, Gullestad L, Fiane A, Thaulow E, Saul JP, Døhlen G (2023)
   Factors Associated With Sinoatrial Reinnervation After Heart Transplantation
   Transplant Direct, 9 (12), e1553
   DOI 10.1097/TXD.0000000000001553, PubMed 37928482
6. Dodgson CS, Beitnes JO, Kløve SF, Herstad J, Opdahl A, Undseth R, Eek CH, Broch K, Gullestad L, Aaberge L, Lunde K, Bendz B, Lie ØH (2023)
   An investigator-sponsored pragmatic randomized controlled trial of AntiCoagulation vs AcetylSalicylic Acid after Transcatheter Aortic Valve Implantation: Rationale and design of ACASA-TAVI
   Am Heart J, 265, 225-232
   DOI 10.1016/j.ahj.2023.08.010, PubMed 37634655
7. Holt MF, Flø A, Bjørnø V, Husebye T, Knudsen EC, Hodt A, Gustavsen A, Kristiansen HA, Raki M, Broch K, Wien TN, Gude E (2023)
   A man in his seventies with fatigue and renal failure
   Tidsskr Nor Laegeforen, 143 (9)
   DOI 10.4045/tidsskr.22.0679, PubMed 37341412
8. Holt MF, Flø A, Ravnestad H, Bjørnø V, Gullestad L, Andreassen AK, Broch K, Gude E (2023)
   Invasive haemodynamics at rest and exercise in cardiac amyloidosis
   ESC Heart Fail, 11 (2), 1263-1268
   DOI 10.1002/ehf2.14621, PubMed 38158705
9. Krämer BK, Hauske SJ, Chilton R, Mann JFE, Gullestad L, Fitchett D, Mattheus M, Steubl D, Wanner C (2023)
   Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetes
   J Diabetes Complications, 37 (9), 108588
   DOI 10.1016/j.jdiacomp.2023.108588, PubMed 37633072
10. Nendl A, Raju SC, Broch K, Mayerhofer CCK, Holm K, Halvorsen B, Lappegård KT, Moscavitch S, Hov JR, Seljeflot I, Trøseid M, Awoyemi A (2023)
    Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
    Front Cardiovasc Med, 10, 1160030
    DOI 10.3389/fcvm.2023.1160030, PubMed 37332580
11. Prapiadou S, Živković L, Thorand B, George MJ, van der Laan SW, Malik R, Herder C, Koenig W, Ueland T, Kleveland O, Aukrust P, Gullestad L, Bernhagen J, Pasterkamp G, Peters A, Hingorani AD, Rosand J, Dichgans M, Anderson CD, Georgakis MK (2023)
    Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis
    Circulation, 149 (9), 669-683
    DOI 10.1161/CIRCULATIONAHA.123.064974, PubMed 38152968
12. Rafique M, Solberg OG, Gullestad L, Bendz B, Murbræch K, Nytrøen K, Rolid K, Lunde K (2023)
    Effects of high-intensity interval training on cardiac remodelling, function and coronary microcirculation in de novo heart transplant patients: a substudy of the HITTS randomised controlled trial
    BMJ Open Sport Exerc Med, 9 (3), e001331
    DOI 10.1136/bmjsem-2022-001331, PubMed 37440977
13. Ravnestad H, Andersen R, Birkeland S, Svalebjørg M, Lingaas PS, Gude E, Gullestad L, Kvitting JP, Broch K, Andreassen AK (2023)
    Pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: Comparison of changes in hemodynamics and functional capacity
    Pulm Circ, 13 (1), e12199
    DOI 10.1002/pul2.12199, PubMed 36788941
14. Sasi A, Romaine A, Erusappan PM, Melleby AO, Hasic A, Dahl CP, Broch K, Almaas VM, Puertas RD, Roderick HL, Lunde IG, Sjaastad I, Vistnes M, Christensen G (2023)
    Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis development
    Matrix Biol Plus, 19-20, 100135
    DOI 10.1016/j.mbplus.2023.100135, PubMed 38076279
15. Solberg OG, Aaberge L, Bosse G, Ueland T, Gullestad L, Aukrust P, Stavem K (2023)
    Microvascular function and inflammatory activation in Takotsubo cardiomyopathy
    ESC Heart Fail, 10 (5), 3216-3222
    DOI 10.1002/ehf2.14461, PubMed 37537779
16. Sverre E, Munkhaugen J, Kristiansen O, Weedon-Fekjaer H, Peersen K, Gjertsen E, Gullestad L, Bergan S, Husebye E, Vethe NT (2023)
    Plasma concentration of atorvastatin metabolites correlates with low-density lipoprotein cholesterol reduction in patients with coronary heart disease
    Pharmacol Res Perspect, 11 (3), e01089
    DOI 10.1002/prp2.1089, PubMed 37186070
17. Woxholt S, Ueland T, Aukrust P, Anstensrud AK, Broch K, Tøllefsen IM, Ryan L, Bendz B, Hopp E, Kløw NE, Seljeflot I, Halvorsen B, Dahl TB, Huse C, Andersen GØ, Gullestad L, Wiseth R, Amundsen BH, Damas JK, Kleveland O (2023)
    Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab
    Open Heart, 10 (2)
    DOI 10.1136/openhrt-2023-002301, PubMed 37591633

Publications 2022

1. Bardan S, Kvaslerud AB, Andresen K, Kløve SF, Edvardsen T, Gullestad L, Broch K (2022)
   Intravenous ferric derisomaltose in iron-deficient patients undergoing transcatheter aortic valve implantation due to severe aortic stenosis: study protocol of the randomised controlled IIISAS trial
   BMJ Open, 12 (9), e059546
   DOI 10.1136/bmjopen-2021-059546, PubMed 36691165
2. Baysa A, Maghazachi AA, Sand KL, Campesan M, Zaglia T, Mongillo M, Giorgio M, Di Lisa F, Gullestad L, Mariero LH, Vaage J, Valen G, Stensløkken KO (2022)
   Toll-like receptor 9 signaling after myocardial infarction: Role of p66ShcA adaptor protein
   Biochem Biophys Res Commun, 644, 70-78
   DOI 10.1016/j.bbrc.2022.12.085, PubMed 36634584
3. Brautaset Englund KV, Østby CM, Broch K, Ueland T, Aukrust P, Gude E, Andreassen AK, Gullestad L (2022)
   Iron homeostasis in heart transplant recipients randomized to ferric derisomaltose or placebo
   Clin Transplant, 36 (7), e14695
   DOI 10.1111/ctr.14695, PubMed 35532871
4. Fontaine MAC, Jin H, Gagliardi M, Rousch M, Wijnands E, Stoll M, Li X, Schurgers L, Reutelingsperger C, Schalkwijk C, van den Akker NMS, Molin DGM, Gullestad L, Eritsland J, Hoffman P, Skjelland M, Andersen GØ, Aukrust P, Karel J, Smirnov E, Halvorsen B, Temmerman L, Biessen EAL (2022)
   Blood Milieu in Acute Myocardial Infarction Reprograms Human Macrophages for Trauma Repair
   Adv Sci (Weinh), 10 (5), e2203053
   DOI 10.1002/advs.202203053, PubMed 36526599
5. Hunt TE, Traaen GM, Aakerøy L, Bendz C, Øverland B, Akre H, Steinshamn S, Loennechen JP, Hegbom F, Broch K, Lie ØH, Lyseggen E, Haugaa KH, Gullestad L, Anfinsen OG (2022)
   Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trial
   Heart Rhythm, 19 (9), 1433-1441
   DOI 10.1016/j.hrthm.2022.06.016, PubMed 35716856
6. Huse C, Anstensrud AK, Michelsen AE, Ueland T, Broch K, Woxholt S, Yang K, Sharma K, Tøllefsen IM, Bendz B, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Quiles-Jiménez A, Bjerkeli V, Bendz C, Kleveland O, Stensaeth KH, Opdahl A, Kløw NE, Andersen GØ, Wiseth R, Halvorsen B, Gullestad L et al. (2022)
   Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial
   EBioMedicine, 80, 104013
   DOI 10.1016/j.ebiom.2022.104013, PubMed 35504178
7. Kvaslerud AB, Bardan S, Andresen K, Kløve SF, Fagerland MW, Edvardsen T, Gullestad L, Broch K (2022)
   Intravenous iron supplement for iron deficiency in patients with severe aortic stenosis scheduled for transcatheter aortic valve implantation: results of the IIISAS randomised trial
   Eur J Heart Fail, 24 (7), 1269-1279
   DOI 10.1002/ejhf.2557, PubMed 35579454
8. Kvaslerud AB, Gude E, Eriksen G, Andreassen AK, Gullestad L, Broch K (2022)
   Diastolic Dysfunction Is Unmasked on Exercise in Patients With Asymptomatic, Severe Aortic Stenosis: An Invasive Hemodynamic Study
   Circ Heart Fail, 15 (2), e009253
   DOI 10.1161/CIRCHEARTFAILURE.121.009253, PubMed 35137599
9. Nygaard S, Christensen AH, Sletner L, Rolid K, Nytrøen K, Gullestad L, Fiane A, Thaulow E, Døhlen G, Saul JP, Wyller VBB (2022)
   Predictors of Hypertension Development 1 Year After Heart Transplantation
   Transplantation, 106 (8), 1656-1665
   DOI 10.1097/TP.0000000000004068, PubMed 35238853
10. Skjølsvik ET, Haugen Lie Ø, Chivulescu M, Ribe M, Castrini AI, Broch K, Pripp AH, Edvardsen T, Haugaa KH (2022)
    Progression of cardiac disease in patients with lamin A/C mutations
    Eur Heart J Cardiovasc Imaging, 23 (4), 543-550
    DOI 10.1093/ehjci/jeab057, PubMed 33824984
11. Traaen GM, Akre H, Loennechen JP, Gullestad L (2022)
    Reply to Lalonde et al.: Why Would Physiologic Support with Continuous Positive Airway Pressure Not Improve Outcomes in Patients with Atrial Fibrillation with Sleep Apnea?
    Am J Respir Crit Care Med, 205 (9), 1129-1130
    DOI 10.1164/rccm.202112-2738LE, PubMed 35226823
12. Vergaro G, Gentile F, Aimo A, Januzzi JL, Richards AM, Lam CSP, de Boer RA, Meems LMG, Latini R, Staszewsky L, Anand IS, Cohn JN, Ueland T, Gullestad L, Aukrust P, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K et al. (2022)
    Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure
    ESC Heart Fail, 9 (4), 2084-2095
    DOI 10.1002/ehf2.13883, PubMed 35510529

Publications 2021

1. Abraham WT, Lindenfeld J, Ponikowski P, Agostoni P, Butler J, Desai AS, Filippatos G, Gniot J, Fu M, Gullestad L, Howlett JG, Nicholls SJ, Redon J, Schenkenberger I, Silva-Cardoso J, Störk S, Krzysztof Wranicz J, Savarese G, Brueckmann M, Jamal W, Nordaby M, Peil B, Ritter I, Ustyugova A, Zeller C et al. (2021)
   Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
   Eur Heart J, 42 (6), 700-710
   DOI 10.1093/eurheartj/ehaa943, PubMed 33351892
2. Ahn JM, Zimmermann FM, Arora S, Solberg OG, Angerås O, Rolid K, Rafique M, Aaberge L, Karason K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Gullestad L, Fearon WF (2021)
   Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation
   Eur Heart J, 42 (48), 4918-4929
   DOI 10.1093/eurheartj/ehab568, PubMed 34665224
3. Ahn JM, Zimmermann FM, Gullestad L, Angerås O, Karason K, Russell K, Lunde K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Solberg OG, Fearon WF (2021)
   Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart Transplantation
   J Am Coll Cardiol, 78 (24), 2425-2435
   DOI 10.1016/j.jacc.2021.10.009, PubMed 34886963
4. Aukrust P, Kleveland O, Gullestad L (2021)
   Targeting IL-6 Trans-Signaling: Amplifying the Benefits of IL-6 Inhibition in Myocardial Infarction
   JACC Basic Transl Sci, 6 (5), 444-446
   DOI 10.1016/j.jacbts.2021.01.007, PubMed 34102669
5. Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegård KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A, Berge RK, Hansen SH, Götz A, Holm K, Aukrust P, Åkra S, Seljeflot I, Solheim S, Lorenzo A, Gullestad L, Trøseid M, Broch K (2021)
   Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
   EBioMedicine, 70, 103511
   DOI 10.1016/j.ebiom.2021.103511, PubMed 34329947
6. Brautaset Englund KV, Østby CM, Rolid K, Gude E, Andreassen AK, Gullestad L, Broch K (2021)
   Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): A randomized clinical trial
   J Heart Lung Transplant, 40 (5), 359-367
   DOI 10.1016/j.healun.2021.01.1390, PubMed 33612360
7. Brautaset Englund KV, Østby CM, Tjønnås G, Gude E, Andreassen AK, Gullestad L, Broch K (2021)
   Prevalence of iron deficiency in heart transplant recipients
   Clin Transplant, 35 (8), e14346
   DOI 10.1111/ctr.14346, PubMed 33969559
8. Broch K, Anstensrud AK, Woxholt S, Andersen GØ, Gullestad L (2021)
   Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial
   J Am Coll Cardiol, 78 (6), 637-638
   DOI 10.1016/j.jacc.2021.06.005, PubMed 34353542
9. Broch K, Anstensrud AK, Woxholt S, Sharma K, Tøllefsen IM, Bendz B, Aakhus S, Ueland T, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Bendz C, Hopp E, Kleveland O, Stensæth KH, Opdahl A, Kløw NE, Seljeflot I, Andersen GØ, Wiseth R, Aukrust P, Gullestad L (2021)
   Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction
   J Am Coll Cardiol, 77 (15), 1845-1855
   DOI 10.1016/j.jacc.2021.02.049, PubMed 33858620
10. Broch K, Brautaset Englund KV, Gullestad L (2021)
    Reply: Safety of intravenous iron in heart transplant patients: Comment to paper by Brautaset Englund et al
    J Heart Lung Transplant, 40 (10), 1247-1248
    DOI 10.1016/j.healun.2021.07.007, PubMed 34384682
11. Bürker BS, Malt UF, Gude E, Grov I, Relbo Authen A, Dew MA, Gullestad L (2021)
    Symptoms of anxiety after heart transplantation and their association with mortality: A secondary analysis
    Clin Transplant, 35 (7), e14323
    DOI 10.1111/ctr.14323, PubMed 33882158
12. Christensen AH, Nygaard S, Rolid K, Nytrøen K, Gullestad L, Fiane A, Thaulow E, Døhlen G, Saul JP, Wyller VBB (2021)
    Early Signs of Sinoatrial Reinnervation in the Transplanted Heart
    Transplantation, 105 (9), 2086-2096
    DOI 10.1097/TP.0000000000003580, PubMed 33323767
13. Christensen AH, Nygaard S, Rolid K, Nytrøen K, Gullestad L, Fiane A, Thaulow E, Døhlen G, Saul JP, Wyller VBB (2021)
    Strong evidence for parasympathetic sinoatrial reinnervation after heart transplantation
    J Heart Lung Transplant, 41 (7), 898-909
    DOI 10.1016/j.healun.2021.11.005, PubMed 34924265
14. Frisk M, Le C, Shen X, Røe ÅT, Hou Y, Manfra O, Silva GJJ, van Hout I, Norden ES, Aronsen JM, Laasmaa M, Espe EKS, Zouein FA, Lambert RR, Dahl CP, Sjaastad I, Lunde IG, Coffey S, Cataliotti A, Gullestad L, Tønnessen T, Jones PP, Altara R, Louch WE (2021)
    Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction
    J Am Coll Cardiol, 77 (4), 405-419
    DOI 10.1016/j.jacc.2020.11.044, PubMed 33509397
15. Helseth R, Kleveland O, Ueland T, Wiseth R, Damas JK, Broch K, Michelsen A, Bendz B, Gullestad L, Aukrust P, Seljeflot I (2021)
    Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
    Open Heart, 8 (1)
    DOI 10.1136/openhrt-2020-001492, PubMed 33972404
16. Holt MF, Michelsen AE, Shahini N, Bjørkelund E, Bendz CH, Massey RJ, Schjalm C, Halvorsen B, Broch K, Ueland T, Gullestad L, Nilsson PH, Aukrust P, Mollnes TE, Louwe MC (2021)
    The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure
    Front Immunol, 12, 800978
    DOI 10.3389/fimmu.2021.800978, PubMed 35003128
17. Kotchetkov R, Susman D, Bhutani D, Broch K, Dispenzieri A, Buadi FK (2021)
    Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein
    Int J Cancer, 148 (11), 2807-2814
    DOI 10.1002/ijc.33483, PubMed 33529362
18. Kotchetkov R, Susman D, Bhutani D, Broch K, Dispenzieri A, Buadi FK (2021)
    Reply to: Comments on: Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein
    Int J Cancer, 149 (3), 743-744
    DOI 10.1002/ijc.33571, PubMed 33742687
19. Kristiansen O, Sverre E, Peersen K, Fagerland MW, Gjertsen E, Gullestad L, Perk J, Dammen T, Husebye E, Vethe NT, Munkhaugen J (2021)
    The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease
    Atherosclerosis, 336, 23-29
    DOI 10.1016/j.atherosclerosis.2021.09.020, PubMed 34610521
20. Kristiansen O, Vethe NT, Peersen K, Wang Fagerland M, Sverre E, Prunés Jensen E, Lindberg M, Gjertsen E, Gullestad L, Perk J, Dammen T, Bergan S, Husebye E, Otterstad JE, Munkhaugen J (2021)
    Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial
    Eur Heart J Cardiovasc Pharmacother, 7 (6), 507-516
    DOI 10.1093/ehjcvp/pvaa076, PubMed 32609361
21. Kvaslerud AB, Santic K, Hussain AI, Auensen A, Fiane A, Skulstad H, Aaberge L, Gullestad L, Broch K (2021)
    Outcomes in asymptomatic, severe aortic stenosis
    PLoS One, 16 (4), e0249610
    DOI 10.1371/journal.pone.0249610, PubMed 33826652
22. Massey RJ, Diep PP, Burman MM, Kvaslerud AB, Brinch L, Aakhus S, Gullestad L, Ruud E, Beitnes JO (2021)
    Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
    Open Heart, 8 (2)
    DOI 10.1136/openhrt-2021-001768, PubMed 34933961
23. Munkhaugen J, Sverre E, Peersen K, Kristiansen O, Gjertsen E, Gullestad L, Erik Otterstad J (2021)
    Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?
    Eur J Prev Cardiol, 28 (8), e10-e11
    DOI 10.1177/2047487320923187, PubMed 33611511
24. Olsen MB, Gregersen I, Sandanger Ø, Yang K, Sokolova M, Halvorsen BE, Gullestad L, Broch K, Aukrust P, Louwe MC (2021)
    Targeting the Inflammasome in Cardiovascular Disease
    JACC Basic Transl Sci, 7 (1), 84-98
    DOI 10.1016/j.jacbts.2021.08.006, PubMed 35128212
25. Rafique M, Solberg OG, Gullestad L, Bendz B, Holm NR, Neghabat O, Dijkstra J, Nytrøen K, Rolid K, Lunde K (2021)
    A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy
    Clin Transplant, 36 (1), e14488
    DOI 10.1111/ctr.14488, PubMed 34747048
26. Traaen GM, Aakerøy L, Hunt TE, Øverland B, Bendz C, Sande LØ, Aakhus S, Fagerland MW, Steinshamn S, Anfinsen OG, Massey RJ, Broch K, Ueland T, Akre H, Loennechen JP, Gullestad L (2021)
    Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial
    Am J Respir Crit Care Med, 204 (5), 573-582
    DOI 10.1164/rccm.202011-4133OC, PubMed 33938787
27. Ueland T, Abraityte A, Norum H, Varathalingam S, Gullestad L, Aukrust P, Andreassen AK (2021)
    Circulating regulators of the wingless pathway in precapillary pulmonary hypertension
    Respirology, 26 (6), 574-581
    DOI 10.1111/resp.14048, PubMed 33830565
28. Ueland T, Gullestad L, Kou L, Young JB, Pfeffer MA, van Veldhuisen DJ, Swedberg K, Mcmurray JJV, Desai AS, Anand IS, Aukrust P (2021)
    Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF
    Clin Res Cardiol, 111 (4), 440-450
    DOI 10.1007/s00392-021-01944-6, PubMed 34611778
29. Vergaro G, Gentile F, Meems LMG, Aimo A, Januzzi JL, Richards AM, Lam CSP, Latini R, Staszewsky L, Anand IS, Cohn JN, Ueland T, Gullestad L, Aukrust P, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Gamble GD et al. (2021)
    NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index Categories
    JACC Heart Fail, 9 (9), 653-663
    DOI 10.1016/j.jchf.2021.05.014, PubMed 34246607
30. Wyller VBB, Nygaard S, Christensen AH, Rolid K, Nytrøen K, Gullestad L, Fiane A, Thaulow E, Døhlen G, Saul JP (2021)
    Functional evidence of low-pressure cardiopulmonary baroreceptor reinnervation 1 year after heart transplantation
    Eur J Appl Physiol, 121 (3), 915-927
    DOI 10.1007/s00421-020-04586-0, PubMed 33389144

Publications 2020

1. Aimo A, Januzzi JL, Vergaro G, Richards AM, Lam CSP, Latini R, Anand IS, Cohn JN, Ueland T, Gullestad L, Aukrust P, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, de Boer RA, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Gamble GD, Ling LH, Leong KTG, Yeo PSD et al. (2020)
   Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T
   Eur J Heart Fail, 22 (11), 2078-2088
   DOI 10.1002/ejhf.1701, PubMed 31919929
2. Arain F, Abraityte A, Bogdanova M, Solberg OG, Michelsen AE, Lekva T, Aakhus S, Holm S, Halvorsen B, Finsen AV, Vinge LE, Nymo S, Espeland T, Ranheim T, Aukrust P, Vaage IJ, Auensen A, Gullestad L, Ueland T (2020)
   YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis
   Circ Heart Fail, 13 (10), e006643
   DOI 10.1161/CIRCHEARTFAILURE.119.006643, PubMed 32962417
3. Bergh N, Gude E, Bartfay SE, K Andreassen A, Arora S, Dahlberg P, Dellgren G, Gullestad L, Gustafsson F, Karason K, Rådegran G, Bollano E, Andersson B (2020)
   Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
   ESC Heart Fail, 7 (2), 567-576
   DOI 10.1002/ehf2.12608, PubMed 32059083
4. Broch K, Gude E, Karason K, Dellgren G, Rådegran G, Gjesdal G, Gustafsson F, Eiskjaer H, Lommi J, Pentikäinen M, Lemström KB, Andreassen AK, Gullestad L (2020)
   Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial
   Clin Transplant, 34 (9), e13984
   DOI 10.1111/ctr.13984, PubMed 32445429
5. Broch K, Popperud T, Gude E, Fløisand Y, Antal EA, Bosse G, Jonsrud C, Hegard T, Skaara S, Elsais A (2020)
   A Middle-Aged Man Presenting With Progressive Heart Failure, Myopathy, and Monoclonal Gammopathy of Uncertain Significance
   JACC Case Rep, 2 (5), 785-789
   DOI 10.1016/j.jaccas.2020.02.024, PubMed 34317348
6. Eriksen-Volnes T, Westheim A, Gullestad L, Slind EK, Grundtvig M (2020)
   β-Blocker Doses and Heart Rate in Patients with Heart Failure: Results from the National Norwegian Heart Failure Registry
   Biomed Hub, 5 (1), 9-18
   DOI 10.1159/000505474, PubMed 32775329
7. George MJ, Kleveland O, Garcia-Hernandez J, Palmen J, Lovering R, Wiseth R, Aukrust P, Engmann J, Damås JK, Hingorani AD, Gullestad L, Casas JP, Ueland T (2020)
   Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform
   J Am Heart Assoc, 9 (12), e015628
   DOI 10.1161/JAHA.119.015628, PubMed 32515246
8. Grundtvig M, Eriksen-Volnes T, Ørn S, Slind EK, Gullestad L (2020)
   6 min walk test is a strong independent predictor of death in outpatients with heart failure
   ESC Heart Fail, 7 (5), 2904-2911
   DOI 10.1002/ehf2.12900, PubMed 32677748
9. Gude E, Hoel TN, Sørensen G, Broch K, Meyer A, Fiane AE (2020)
   Long-term continuous flow mechanical biventricular support: 9 years and counting
   Interact Cardiovasc Thorac Surg, 30 (1), 81-84
   DOI 10.1093/icvts/ivz231, PubMed 31580433
10. Gustafsson F, Andreassen AK, Andersson B, Eiskjær H, Rådegran G, Gude E, Jansson K, Solbu D, Karason K, Arora S, Dellgren G, Gullestad L, SCHEDULE (Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance) Investigators* (2020)
    Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study
    Transplantation, 104 (1), 154-164
    DOI 10.1097/TP.0000000000002702, PubMed 30893292
11. Kristiansen S, Traaen GM, Øverland B, Plagemann T, Gullestad L, Akre H, Nikolaidis K, Aakerøy L, Hunt TE, Loennechen JP, Steinshamn S, Bendz C, Anfinsen OG, Goebel V (2020)
    Comparing manual and automatic scoring of sleep monitoring data from portable polygraphy
    J Sleep Res, 30 (2), e13036
    DOI 10.1111/jsr.13036, PubMed 32430962
12. Kummen M, Solberg OG, Storm-Larsen C, Holm K, Ragnarsson A, Trøseid M, Vestad B, Skårdal R, Yndestad A, Ueland T, Svardal A, Berge RK, Seljeflot I, Gullestad L, Karlsen TH, Aaberge L, Aukrust P, Hov JR (2020)
    Rosuvastatin alters the genetic composition of the human gut microbiome
    Sci Rep, 10 (1), 5397
    DOI 10.1038/s41598-020-62261-y, PubMed 32214138
13. Lekva T, Gullestad L, Broch K, Aukrust P, Andreassen AK, Ueland T (2020)
    Distinct patterns of soluble leukocyte activation markers are associated with etiology and outcomes in precapillary pulmonary hypertension
    Sci Rep, 10 (1), 18540
    DOI 10.1038/s41598-020-75654-w, PubMed 33122779
14. Massey RJ, Diep PP, Ruud E, Burman MM, Kvaslerud AB, Brinch L, Aakhus S, Gullestad LL, Beitnes JO (2020)
    Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation
    JACC CardioOncol, 2 (3), 460-471
    DOI 10.1016/j.jaccao.2020.06.011, PublikaID 352
15. Mayerhofer CCK, Kummen M, Holm K, Broch K, Awoyemi A, Vestad B, Storm-Larsen C, Seljeflot I, Ueland T, Bohov P, Berge RK, Svardal A, Gullestad L, Yndestad A, Aukrust P, Hov JR, Trøseid M (2020)
    Low fibre intake is associated with gut microbiota alterations in chronic heart failure
    ESC Heart Fail, 7 (2), 456-466
    DOI 10.1002/ehf2.12596, PubMed 31978943
16. Nelson LM, Andreassen AK, Arora S, Andersson B, Gude E, Eiskjaer H, Rådegran G, Dellgren G, Gullestad L, Gustafsson F (2020)
    Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients-a SCHEDULE trial substudy
    Transpl Int, 33 (5), 517-528
    DOI 10.1111/tri.13577, PubMed 31958178
17. Niyonzima N, Bakke SS, Gregersen I, Holm S, Sandanger Ø, Orrem HL, Sporsheim B, Ryan L, Kong XY, Dahl TB, Skjelland M, Sørensen KK, Rokstad AM, Yndestad A, Latz E, Gullestad L, Andersen GØ, Damås JK, Aukrust P, Mollnes TE, Halvorsen B, Espevik T (2020)
    Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis
    EBioMedicine, 60, 102985
    DOI 10.1016/j.ebiom.2020.102985, PubMed 32927275
18. Nytrøen K, Rolid K, Yardley M, Gullestad L (2020)
    Effect of high-intensity interval training in young heart transplant recipients: results from two randomized controlled trials
    BMC Sports Sci Med Rehabil, 12, 35
    DOI 10.1186/s13102-020-00180-1, PubMed 32518655
19. Peersen K, Otterstad JE, Sverre E, Perk J, Gullestad L, Moum T, Dammen T, Munkhaugen J (2020)
    Medical and Psychosocial Factors Associated With Low Physical Activity and Increasing Exercise Level After a Coronary Event
    J Cardiopulm Rehabil Prev, 40 (1), 35-40
    DOI 10.1097/HCR.0000000000000399, PubMed 30720643
20. Rolid K, Andreassen AK, Yardley M, Gude E, Bjørkelund E, Authen AR, Grov I, Broch K, Gullestad L, Nytrøen K (2020)
    Long-term effects of high-intensity training vs moderate intensity training in heart transplant recipients: A 3-year follow-up study of the randomized-controlled HITTS study
    Am J Transplant, 20 (12), 3538-3549
    DOI 10.1111/ajt.16087, PubMed 32484261
21. Rolid K, Andreassen AK, Yardley M, Gude E, Bjørkelund E, Authen AR, Grov I, Pettersen KI, Dall CH, Karason K, Broch K, Gullestad L, Nytrøen K (2020)
    High-intensity interval training and health-related quality of life in de novo heart transplant recipients - results from a randomized controlled trial
    Health Qual Life Outcomes, 18 (1), 283
    DOI 10.1186/s12955-020-01536-4, PubMed 32807179
22. Sverre E, Peersen K, Perk J, Husebye E, Gullestad L, Dammen T, Otterstad JE, Munkhaugen J (2020)
    Challenges in coronary heart disease prevention - experiences from a long-term follow-up study in Norway
    Scand Cardiovasc J, 55 (2), 73-81
    DOI 10.1080/14017431.2020.1852308, PubMed 33274648
23. Sverre E, Peersen K, Weedon-Fekjær H, Perk J, Gjertsen E, Husebye E, Gullestad L, Dammen T, Otterstad JE, Munkhaugen J (2020)
    Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population
    BMC Cardiovasc Disord, 20 (1), 61
    DOI 10.1186/s12872-020-01368-6, PubMed 32024471
24. Tegn N, Eek C, Abdelnoor M, Aaberge L, Endresen K, Skårdal R, Berg ES, Gullestad L, Bendz B (2020)
    Patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris randomised to an invasive versus conservative strategy: angiographic and procedural results from the After Eighty study
    Open Heart, 7 (2)
    DOI 10.1136/openhrt-2020-001256, PubMed 32719073
25. Trøseid M, Andersen GØ, Broch K, Hov JR (2020)
    The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
    EBioMedicine, 52, 102649
    DOI 10.1016/j.ebiom.2020.102649, PubMed 32062353
26. Ueland T, Estensen ME, Grindheim G, Bollerslev J, Henriksen T, Aukrust P, Aakhus S, Gullestad L, Lekva T (2020)
    Elevated levels of the secreted wingless agonist R-spondin 3 in preeclamptic pregnancies
    J Hypertens, 38 (7), 1347-1354
    DOI 10.1097/HJH.0000000000002362, PubMed 31990902

Publications 2019

1. Andreassen AK, Broch K, Eiskjær H, Karason K, Gude E, Mølbak D, Stueflotten W, Gullestad L, SCHEDULE (SCandinavian HEart transplant everolimus De-novo stUdy with earLy calcineurin inhibitors avoidancE) Investigators (2019)
   Blood Pressure in De Novo Heart Transplant Recipients Treated With Everolimus Compared With a Cyclosporine-based Regimen: Results From the Randomized SCHEDULE Trial
   Transplantation, 103 (4), 781-788
   DOI 10.1097/TP.0000000000002445, PubMed 30211826
2. Anstensrud AK, Woxholt S, Sharma K, Broch K, Bendz B, Aakhus S, Ueland T, Amundsen BH, Damås JK, Hopp E, Kleveland O, Stensæth KH, Opdahl A, Kløw NE, Seljeflot I, Andersen GØ, Wiseth R, Aukrust P, Gullestad L (2019)
   Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
   Open Heart, 6 (2), e001108
   DOI 10.1136/openhrt-2019-001108, PubMed 31673391
3. Arora S, Ofstad AP, Ulimoen GR, Birkeland KI, Endresen K, Gullestad L, Johansen OE (2019)
   Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation
   Cardiovasc Diabetol, 18 (1), 26
   DOI 10.1186/s12933-019-0832-2, PubMed 30851727
4. Bürker BS, Gullestad L, Gude E, Havik OE, Relbo Authen A, Grov I, Andreassen AK, Fiane AE, Haraldsen IR, Dew MA, Andersson S, Malt UF (2019)
   The Predictive Value of Depression in the Years After Heart Transplantation for Mortality During Long-Term Follow-Up
   Psychosom Med, 81 (6), 513-520
   DOI 10.1097/PSY.0000000000000702, PubMed 31033937
5. Dangas GD, Tijssen JGP, Wöhrle J, Søndergaard L, Gilard M, Möllmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S, De Backer O, Guimarães AHC, Gullestad L, Kini A, von Lewinski D, Mack M, Moreno R, Schäfer U, Seeger J, Tchétché D, Thomitzek K, Valgimigli M, Vranckx P, Welsh RC, Wildgoose P et al. (2019)
   A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
   N Engl J Med, 382 (2), 120-129
   DOI 10.1056/NEJMoa1911425, PubMed 31733180
6. Fosshaug LE, Colas RA, Anstensrud AK, Gregersen I, Nymo S, Sagen EL, Michelsen A, Vinge LE, Øie E, Gullestad L, Halvorsen B, Hansen TV, Aukrust P, Dalli J, Yndestad A (2019)
   Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction
   EBioMedicine, 46, 264-273
   DOI 10.1016/j.ebiom.2019.07.024, PubMed 31345784
7. Lunde NN, Gregersen I, Ueland T, Shetelig C, Holm S, Kong XY, Michelsen AE, Otterdal K, Yndestad A, Broch K, Gullestad L, Nyman TA, Bendz B, Eritsland J, Hoffmann P, Skagen K, Gonçalves I, Nilsson J, Grenegård M, Poreba M, Drag M, Seljeflot I, Sporsheim B, Espevik T, Skjelland M et al. (2019)
   Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages
   Atherosclerosis, 296, 74-82
   DOI 10.1016/j.atherosclerosis.2019.12.008, PubMed 31870625
8. Mayerhofer CCK, Awoyemi A, Hov JR, Trøseid M, Broch K (2019)
   Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failure
   ESC Heart Fail, 6 (3), 557-558
   DOI 10.1002/ehf2.12437, PubMed 31034162
9. Munkhaugen J, Vethe NT, Fagerland MW, Dammen T, Perk J, Gjertsen E, Otterstad JE, Gullestad L, Bergan S, Husebye E (2019)
   Statin-associated muscle symptoms in coronary patients: design of a randomized study
   Scand Cardiovasc J, 53 (3), 162-168
   DOI 10.1080/14017431.2019.1612085, PubMed 31030568
10. Nygaard S, Christensen AH, Rolid K, Nytrøen K, Gullestad L, Fiane A, Thaulow E, Døhlen G, Godang K, Saul JP, Wyller VBB (2019)
    Autonomic cardiovascular control changes in recent heart transplant recipients lead to physiological limitations in response to orthostatic challenge and isometric exercise
    Eur J Appl Physiol, 119 (10), 2225-2236
    DOI 10.1007/s00421-019-04207-5, PubMed 31407088
11. Nytrøen K, Rolid K, Andreassen AK, Yardley M, Gude E, Dahle DO, Bjørkelund E, Relbo Authen A, Grov I, Philip Wigh J, Have Dall C, Gustafsson F, Karason K, Gullestad L (2019)
    Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients in Scandinavia
    Circulation, 139 (19), 2198-2211
    DOI 10.1161/CIRCULATIONAHA.118.036747, PubMed 30773030
12. Nytrøen K, Rolid K, Gullestad L (2019)
    Response by Nytrøen et al to Letter Regarding Article, "Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients in Scandinavia"
    Circulation, 140 (17), e735-e736
    DOI 10.1161/CIRCULATIONAHA.119.042458, PubMed 31634012
13. Shahini N, Ueland T, Auensen A, Michelsen AE, Ludviksen JK, Hussain AI, Pettersen KI, Aakhus S, Espeland T, Lunde IG, Kirschfink M, Nilsson PH, Mollnes TE, Gullestad L, Aukrust P, Yndestad A, Louwe MC (2019)
    Increased Complement Factor B and Bb Levels Are Associated with Mortality in Patients with Severe Aortic Stenosis
    J Immunol, 203 (7), 1973-1980
    DOI 10.4049/jimmunol.1801244, PubMed 31492744
14. Solberg OG, Stavem K, Ragnarsson A, Beitnes JO, Skårdal R, Seljeflot I, Ueland T, Aukrust P, Gullestad L, Aaberge L (2019)
    Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study
    Catheter Cardiovasc Interv, 94 (5), 660-668
    DOI 10.1002/ccd.28157, PubMed 30790446
15. Trøseid M, Mayerhofer CCK, Broch K, Arora S, Svardal A, Hov JR, Andreassen AK, Gude E, Karason K, Dellgren G, Berge RK, Gullestad L, Aukrust P, Ueland T (2019)
    The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection
    J Heart Lung Transplant, 38 (10), 1097-1103
    DOI 10.1016/j.healun.2019.06.003, PubMed 31301965
16. Traaen GM, Øverland B, Aakerøy L, Hunt TE, Bendz C, Sande L, Aakhus S, Zaré H, Steinshamn S, Anfinsen OG, Loennechen JP, Gullestad L, Akre H (2019)
    Prevalence, risk factors, and type of sleep apnea in patients with paroxysmal atrial fibrillation
    Int J Cardiol Heart Vasc, 26, 100447
    DOI 10.1016/j.ijcha.2019.100447, PubMed 32140547

Publications 2018

1. Abraityte A, Aukrust P, Kou L, Anand IS, Young J, Mcmurray JJV, van Veldhuisen DJ, Gullestad L, Ueland T (2018)
   T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF
   Clin Res Cardiol, 108 (2), 133-141
   DOI 10.1007/s00392-018-1331-2, PubMed 30051179
2. Arora S, Andreassen AK, Karason K, Gustafsson F, Eiskjær H, Bøtker HE, Rådegran G, Gude E, Ioanes D, Solbu D, Dellgren G, Ueland T, Aukrust P, Gullestad L, SCHEDULE (Scandinavian Heart Transplant Everolimus De Novo Study With Early Calcineurin Inhibitors Avoidance) Investigators (2018)
   Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients
   Circ Heart Fail, 11 (9), e004050
   DOI 10.1161/CIRCHEARTFAILURE.117.004050, PubMed 30354362
3. Cosmi F, Shen L, Magnoli M, Abraham WT, Anand IS, Cleland JG, Cohn JN, Cosmi D, De Berardis G, Dickstein K, Franzosi MG, Gullestad L, Jhund PS, Kjekshus J, Køber L, Lepore V, Lucisano G, Maggioni AP, Masson S, McMurray JJV, Nicolucci A, Petrarolo V, Robusto F, Staszewsky L, Tavazzi L et al. (2018)
   Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes
   Eur J Heart Fail, 20 (5), 888-895
   DOI 10.1002/ejhf.1146, PubMed 29488676
4. Emdin M, Aimo A, Vergaro G, Bayes-Genis A, Lupón J, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Gullestad L, Broch K, Ueland T, Nymo SH, Brunner-La Rocca HP, de Boer RA, Gaggin HK, Ripoli A, Passino C, Januzzi JL (2018)
   sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T
   J Am Coll Cardiol, 72 (19), 2309-2320
   DOI 10.1016/j.jacc.2018.08.2165, PubMed 30384887
5. Espeland T, Lunde IG, Amundsen BH, Gullestad L, Aakhus S (2018)
   [Espeland and co-workers respond]
   Tidsskr Nor Laegeforen, 138 (19)
   DOI 10.4045/tidsskr.18.0865, PubMed 30497251
6. Espeland T, Lunde IG, Amundsen BH, Gullestad L, Aakhus S (2018)
   Myocardial Fibrosis
   Tidsskr. Nor. Laegeforen., 138 (16), 1533-1539
7. Espeland T, Lunde IG, H Amundsen B, Gullestad L, Aakhus S (2018)
   Myocardial fibrosis
   Tidsskr Nor Laegeforen, 138 (16)
   DOI 10.4045/tidsskr.17.1027, PubMed 30344312
8. Heier M, Ofstad AP, Borja MS, Brunborg C, Endresen K, Gullestad L, Birkeland KI, Johansen OE, Oda MN (2018)
   High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes
   Atherosclerosis, 282, 183-187
   DOI 10.1016/j.atherosclerosis.2018.07.005, PubMed 30017177
9. Hussain AI, Auensen A, Brunborg C, Beitnes JO, Gullestad L, Pettersen KI (2018)
   Age-dependent morbidity and mortality outcomes after surgical aortic valve replacement
   Interact Cardiovasc Thorac Surg, 27 (5), 650-656
   DOI 10.1093/icvts/ivy154, PubMed 29746650
10. Kleveland O, Ueland T, Kunszt G, Bratlie M, Yndestad A, Broch K, Holte E, Ryan L, Amundsen BH, Bendz B, Aakhus S, Espevik T, Halvorsen B, Mollnes TE, Wiseth R, Gullestad L, Aukrust P, Damås JK (2018)
    Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction
    Int J Cardiol, 271, 1-7
    DOI 10.1016/j.ijcard.2018.04.136, PubMed 29961572
11. Kummen M, Mayerhofer CCK, Vestad B, Broch K, Awoyemi A, Storm-Larsen C, Ueland T, Yndestad A, Hov JR, Trøseid M (2018)
    Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts
    J Am Coll Cardiol, 71 (10), 1184-1186
    DOI 10.1016/j.jacc.2017.12.057, PubMed 29519360
12. Kvaslerud AB, Hussain AI, Auensen A, Ueland T, Michelsen AE, Pettersen KI, Aukrust P, Mørkrid L, Gullestad L, Broch K (2018)
    Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis
    Open Heart, 5 (2), e000901
    DOI 10.1136/openhrt-2018-000901, PubMed 30613413
13. Mayerhofer CCK, Awoyemi AO, Moscavitch SD, Lappegård KT, Hov JR, Aukrust P, Hovland A, Lorenzo A, Halvorsen S, Seljeflot I, Gullestad L, Trøseid M, Broch K (2018)
    Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
    ESC Heart Fail, 5 (5), 977-984
    DOI 10.1002/ehf2.12332, PubMed 30088346
14. Munkhaugen J, Hjelmesæth J, Otterstad JE, Helseth R, Sollid ST, Gjertsen E, Gullestad L, Perk J, Moum T, Husebye E, Dammen T (2018)
    Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study
    BMC Cardiovasc Disord, 18 (1), 160
    DOI 10.1186/s12872-018-0896-z, PubMed 30075751
15. Munkhaugen J, Otterstad JE, Dammen T, Gjertsen E, Moum T, Husebye E, Gullestad L (2018)
    The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event
    Eur J Prev Cardiol, 25 (9), 923-931
    DOI 10.1177/2047487318768940, PubMed 29635941
16. Munkhaugen J, Peersen K, Sverre E, Gjertsen E, Gullestad L, Dammen T, Husebye E, Otterstad JE (2018)
    The follow-up after myocardial infarction - is it good enough?
    Tidsskr Nor Laegeforen, 138 (5)
    DOI 10.4045/tidsskr.17.1050, PubMed 29513442
17. Munkhaugen J, Peersen K, Sverre E, Gjertsen E, Gullestad L, Dammen T, Husebye E, Otterstad JE (2018)
    The follow-up after myocardial infarction- is it good enough?
    Tidsskr. Nor. Laegeforen., 138 (5), 434-437
18. Norum HM, Michelsen AE, Lekva T, Arora S, Otterdal K, Olsen MB, Kong XY, Gude E, Andreassen AK, Solbu D, Karason K, Dellgren G, Gullestad L, Aukrust P, Ueland T (2018)
    Circulating delta-like Notch ligand 1 is correlated with cardiac allograft vasculopathy and suppressed in heart transplant recipients on everolimus-based immunosuppression
    Am J Transplant, 19 (4), 1050-1060
    DOI 10.1111/ajt.15141, PubMed 30312541
19. Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE (2018)
    The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions
    Heart Fail Rev, 23 (3), 303-323
    DOI 10.1007/s10741-018-9685-0, PubMed 29516230
20. Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE (2018)
    Response to the editor
    Heart Fail Rev (in press)
    DOI 10.1007/s10741-018-9723-y, PubMed 29968222
21. Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE (2018)
    Author's response to: letter to the editor
    Heart Fail Rev, 23 (5), 819
    DOI 10.1007/s10741-018-9728-6, PubMed 30043131
22. Orrem HL, Nilsson PH, Pischke SE, Kleveland O, Yndestad A, Ekholt K, Damås JK, Espevik T, Bendz B, Halvorsen B, Gregersen I, Wiseth R, Andersen GØ, Ueland T, Gullestad L, Aukrust P, Barratt-Due A, Mollnes TE (2018)
    IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
    Front Immunol, 9, 2035
    DOI 10.3389/fimmu.2018.02035, PubMed 30258440
23. Rolid K, Andreassen AK, Yardley M, Bjørkelund E, Karason K, Wigh JP, Dall CH, Gustafsson F, Gullestad L, Nytrøen K (2018)
    Clinical features and determinants of VO_2peak in de novo heart transplant recipients
    World J Transplant, 8 (5), 188-197
    DOI 10.5500/wjt.v8.i5.188, PubMed 30211027
24. Tegn N, Abdelnoor M, Aaberge L, Hylen Ranhoff A, Endresen K, Gjertsen E, Skårdal R, Gullestad L, Bendz B, After Eighty study investigators (2018)
    Health-related quality of life in older patients with acute coronary syndrome randomised to an invasive or conservative strategy. The After Eighty randomised controlled trial
    Age Ageing, 47 (1), 42-47
    DOI 10.1093/ageing/afx121, PubMed 28985265
25. Traaen GM, Aakerøy L, Hunt TE, Øverland B, Lyseggen E, Aukrust P, Ueland T, Helle-Valle T, Steinshamn S, Edvardsen T, Khiabani Zaré H, Aakhus S, Akre H, Anfinsen OG, Loennechen JP, Gullestad L (2018)
    Treatment of sleep apnea in patients with paroxysmal atrial fibrillation: design and rationale of a randomized controlled trial
    Scand Cardiovasc J, 52 (6), 372-377
    DOI 10.1080/14017431.2019.1567933, PubMed 30638392
26. Ueland T, Gullestad L, Kou L, Aukrust P, Anand IS, Broughton MN, McMurray JJ, van Veldhuisen DJ, Warren DJ, Bolstad N (2018)
    Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study
    ESC Heart Fail, 5 (6), 1052-1059
    DOI 10.1002/ehf2.12312, PubMed 30145817
27. Ueland T, Kleveland O, Michelsen AE, Wiseth R, Damås JK, Aukrust P, Gullestad L, Halvorsen B, Yndestad A (2018)
    Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
    Open Heart, 5 (2), e000765
    DOI 10.1136/openhrt-2017-000765, PubMed 30258647
28. Ueland T, Kleveland O, Michelsen AE, Wiseth R, Damås JK, Holven KB, Aukrust P, Gullestad L, Yndestad A, Halvorsen B (2018)
    Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction
    Int J Cardiol, 274, 348-350
    DOI 10.1016/j.ijcard.2018.06.093, PubMed 29961573
29. Yardley M, Gullestad L, Nytrøen K (2018)
    Importance of physical capacity and the effects of exercise in heart transplant recipients
    World J Transplant, 8 (1), 1-12
    DOI 10.5500/wjt.v8.i1.1, PubMed 29507857

Publications 2017

1. Abraityte A, Lunde IG, Askevold ET, Michelsen AE, Christensen G, Aukrust P, Yndestad A, Fiane A, Andreassen A, Aakhus S, Dahl CP, Gullestad L, Broch K, Ueland T (2017)
   Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy
   Sci Rep, 7 (1), 3490
   DOI 10.1038/s41598-017-03625-9, PubMed 28615692
2. Abraityte A, Vinge LE, Askevold ET, Lekva T, Michelsen AE, Ranheim T, Alfsnes K, Fiane A, Aakhus S, Lunde IG, Dahl CP, Aukrust P, Christensen G, Gullestad L, Yndestad A, Ueland T (2017)
   Wnt5a is elevated in heart failure and affects cardiac fibroblast function
   J Mol Med (Berl), 95 (7), 767-777
   DOI 10.1007/s00109-017-1529-1, PubMed 28357477
3. Auensen A, Hussain AI, Bendz B, Aaberge L, Falk RS, Walle-Hansen MM, Bye J, Andreassen J, Beitnes JO, Rein KA, Pettersen KI, Gullestad L (2017)
   Morbidity outcomes after surgical aortic valve replacement
   Open Heart, 4 (1), e000588
   DOI 10.1136/openhrt-2017-000588, PubMed 28674629
4. Broch K, de Marchi SF, Massey R, Hisdal J, Aakhus S, Gullestad L, Urheim S (2017)
   Left Ventricular Contraction Pattern in Chronic Aortic Regurgitation and Preserved Ejection Fraction: Simultaneous Stress-Strain Analysis by Three-Dimensional Echocardiography
   J Am Soc Echocardiogr, 30 (4), 422-430.e2
   DOI 10.1016/j.echo.2016.11.012, PubMed 28065583
5. Broch K, Leren IS, Saberniak J, Ueland T, Edvardsen T, Gullestad L, Haugaa KH (2017)
   Soluble ST2 is associated with disease severity in arrhythmogenic right ventricular cardiomyopathy
   Biomarkers, 22 (3-4), 367-371
   DOI 10.1080/1354750X.2016.1278266, PubMed 28067540
6. Bürker BS, Gude E, Gullestad L, Grov I, Relbo Authen A, Andreassen AK, Havik OE, Dew MA, Fiane AE, Haraldsen IR, Malt UF, Andersson S (2017)
   Cognitive function among long-term survivors of heart transplantation
   Clin Transplant, 31 (12)
   DOI 10.1111/ctr.13143, PubMed 29055147
7. Bürker BS, Gullestad L, Gude E, Relbo Authen A, Grov I, Hol PK, Andreassen AK, Arora S, Dew MA, Fiane AE, Haraldsen IR, Malt UF, Andersson S (2017)
   Cognitive function after heart transplantation: Comparing everolimus-based and calcineurin inhibitor-based regimens
   Clin Transplant, 31 (4)
   DOI 10.1111/ctr.12927, PubMed 28185318
8. Gude E, Gullestad L, Andreassen AK (2017)
   Everolimus immunosuppression for renal protection, reduction of allograft vasculopathy and prevention of allograft rejection in de-novo heart transplant recipients: could we have it all?
   Curr Opin Organ Transplant, 22 (3), 198-206
   DOI 10.1097/MOT.0000000000000409, PubMed 28463861
9. Günther A, Andersen R, Gude E, Jakobsen J, Edvardsen T, Sandvik L, Abildgaard A, Aaberge L, Gullestad L (2017)
   The predictive value of coronary artery calcium detected by computed tomography in a prospective study on cardiac allograft vasculopathy in heart transplant patients
   Transpl Int, 31 (1), 82-91
   DOI 10.1111/tri.13057, PubMed 28865096
10. Holte E, Kleveland O, Ueland T, Kunszt G, Bratlie M, Broch K, Michelsen AE, Bendz B, Amundsen BH, Aakhus S, Damås JK, Gullestad L, Aukrust P, Wiseth R (2017)
    Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction
    Heart, 103 (19), 1521-1527
    DOI 10.1136/heartjnl-2016-310875, PubMed 28432157
11. Hussain AI, Auensen A, Brunborg C, Aakhus S, Fiane A, Pettersen KI, Gullestad L (2017)
    Determinants and Outcome of Decision Making Among Patients with Severe Aortic Stenosis
    J Heart Valve Dis, 26 (4), 413-422
    PubMed 29302940
12. Klaeboe LG, Haland TF, Leren IS, Ter Bekke RMA, Brekke PH, Røsjø H, Omland T, Gullestad L, Aakhus S, Haugaa KH, Edvardsen T (2017)
    Prognostic Value of Left Ventricular Deformation Parameters in Patients with Severe Aortic Stenosis: A Pilot Study of the Usefulness of Strain Echocardiography
    J Am Soc Echocardiogr, 30 (8), 727-735.e1
    DOI 10.1016/j.echo.2017.04.009, PubMed 28599826
13. Mayerhofer CCK, Ueland T, Broch K, Vincent RP, Cross GF, Dahl CP, Aukrust P, Gullestad L, Hov JR, Trøseid M (2017)
    Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure
    J Card Fail, 23 (9), 666-671
    DOI 10.1016/j.cardfail.2017.06.007, PubMed 28688889
14. Munkhaugen J, Sverre E, Otterstad JE, Peersen K, Gjertsen E, Perk J, Gullestad L, Moum T, Dammen T, Husebye E (2017)
    Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients
    Eur J Prev Cardiol, 24 (9), 981-989
    DOI 10.1177/2047487317693134, PubMed 28196429
15. Nelson LM, Andreassen AK, Andersson B, Gude E, Eiskjær H, Rådegran G, Dellgren G, Gullestad L, Gustafsson F (2017)
    Effect of Calcineurin Inhibitor-Free, Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate After Heart Transplantation
    Transplantation, 101 (11), 2793-2800
    DOI 10.1097/TP.0000000000001706, PubMed 28230646
16. Norum HM, Broch K, Michelsen AE, Lunde IG, Lekva T, Abraityte A, Dahl CP, Fiane AE, Andreassen AK, Christensen G, Aakhus S, Aukrust P, Gullestad L, Ueland T (2017)
    The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated Cardiomyopathy
    J Cardiovasc Transl Res, 10 (4), 401-410
    DOI 10.1007/s12265-017-9748-y, PubMed 28474304
17. Nymo SH, Aukrust P, Kjekshus J, McMurray JJ, Cleland JG, Wikstrand J, Muntendam P, Wienhues-Thelen U, Latini R, Askevold ET, Gravning J, Dahl CP, Broch K, Yndestad A, Gullestad L, Ueland T, CORONA Study Group (2017)
    Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure
    JACC Heart Fail, 5 (4), 256-264
    DOI 10.1016/j.jchf.2017.01.008, PubMed 28359413
18. Olsen MB, Hildrestrand GA, Scheffler K, Vinge LE, Alfsnes K, Palibrk V, Wang J, Neurauter CG, Luna L, Johansen J, Øgaard JDS, Ohm IK, Slupphaug G, Kuśnierczyk A, Fiane AE, Brorson SH, Zhang L, Gullestad L, Louch WE, Iversen PO, Østlie I, Klungland A, Christensen G, Sjaastad I, Sætrom P et al. (2017)
    NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial Rupture
    Cell Rep, 18 (1), 82-92
    DOI 10.1016/j.celrep.2016.12.009, PubMed 28052262
19. Peersen K, Munkhaugen J, Gullestad L, Dammen T, Moum T, Otterstad JE (2017)
    Reproducibility of an extensive self-report questionnaire used in secondary coronary prevention
    Scand J Public Health, 45 (3), 269-276
    DOI 10.1177/1403494816688375, PubMed 28181463
20. Peersen K, Munkhaugen J, Gullestad L, Liodden T, Moum T, Dammen T, Perk J, Otterstad JE (2017)
    The role of cardiac rehabilitation in secondary prevention after coronary events
    Eur J Prev Cardiol, 24 (13), 1360-1368
    DOI 10.1177/2047487317719355, PubMed 28664773
21. Relbo Authen A, Grov I, Karason K, Gustafsson F, Eiskjaer H, Rådegran G, Gude E, Jansson K, Dellgren G, Solbu D, Arora S, Andreassen AK, Gullestad L (2017)
    Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE)
    Clin Transplant, 31 (9)
    DOI 10.1111/ctr.13038, PubMed 28640529
22. Rutkovskiy A, Sagave J, Czibik G, Baysa A, Zihlavnikova Enayati K, Hillestad V, Dahl CP, Fiane A, Gullestad L, Gravning J, Ahmed S, Attramadal H, Valen G, Vaage J (2017)
    Connective tissue growth factor and bone morphogenetic protein 2 are induced following myocardial ischemia in mice and humans
    Scand J Clin Lab Invest, 77 (5), 321-331
    DOI 10.1080/00365513.2017.1318447, PubMed 28460577
23. Shahini N, Michelsen AE, Nilsson PH, Ekholt K, Gullestad L, Broch K, Dahl CP, Aukrust P, Ueland T, Mollnes TE, Yndestad A, Louwe MC (2017)
    The alternative complement pathway is dysregulated in patients with chronic heart failure
    Sci Rep, 7, 42532
    DOI 10.1038/srep42532, PubMed 28195242
24. Sverre E, Otterstad JE, Gjertsen E, Gullestad L, Husebye E, Dammen T, Moum T, Munkhaugen J (2017)
    Medical and sociodemographic factors predict persistent smoking after coronary events
    BMC Cardiovasc Disord, 17 (1), 241
    DOI 10.1186/s12872-017-0676-1, PubMed 28877684
25. Sverre E, Peersen K, Husebye E, Gjertsen E, Gullestad L, Moum T, Otterstad JE, Dammen T, Munkhaugen J (2017)
    Unfavourable risk factor control after coronary events in routine clinical practice
    BMC Cardiovasc Disord, 17 (1), 40
    DOI 10.1186/s12872-016-0387-z, PubMed 28109259
26. Sverre E, Peersen K, Otterstad JE, Gullestad L, Perk J, Gjertsen E, Moum T, Husebye E, Dammen T, Munkhaugen J (2017)
    Optimal blood pressure control after coronary events: the challenge remains
    J Am Soc Hypertens, 11 (12), 823-830
    DOI 10.1016/j.jash.2017.10.007, PubMed 29128603
27. Welsh P, Kou L, Yu C, Anand I, van Veldhuisen DJ, Maggioni AP, Desai AS, Solomon SD, Pfeffer MA, Cheng S, Gullestad L, Aukrust P, Ueland T, Swedberg K, Young JB, Kattan MW, Sattar N, McMurray JJV (2017)
    Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study
    Eur J Heart Fail, 20 (2), 268-277
    DOI 10.1002/ejhf.988, PubMed 28960777
28. Yardley M, Ueland T, Aukrust P, Michelsen A, Bjørkelund E, Gullestad L, Nytrøen K (2017)
    Immediate response in markers of inflammation and angiogenesis during exercise: a randomised cross-over study in heart transplant recipients
    Open Heart, 4 (2), e000635
    DOI 10.1136/openhrt-2017-000635, PubMed 29225901

Publications 2016

1. Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Rådegran G, Gude E, Jansson K, Solbu D, Karason K, Arora S, Dellgren G, Gullestad L, SCHEDULE investigators (2016)
   Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study
   Am J Transplant, 16 (4), 1238-47
   DOI 10.1111/ajt.13588, PubMed 26820618
2. Arain F, Gullestad L, Nymo S, Kjekshus J, Cleland JG, Michelsen A, McMurray JJ, Wikstrand J, Aukrust P, Ueland T (2016)
   Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA)
   Biomarkers, 22 (3-4), 261-267
   DOI 10.1080/1354750X.2016.1204003, PubMed 27325138
3. Broch K, Urheim S, Massey R, Stueflotten W, Fosså K, Hopp E, Aakhus S, Gullestad L (2016)
   Exercise capacity and peak oxygen consumption in asymptomatic patients with chronic aortic regurgitation
   Int J Cardiol, 223, 688-692
   DOI 10.1016/j.ijcard.2016.08.237, PubMed 27568990
4. Dhondup Y, Ueland T, Dahl CP, Askevold ET, Sandanger Ø, Fiane A, Ohm IK, Sjaastad I, Finsen AV, Wæhre A, Gullestad L, Aukrust P, Yndestad A, Vinge LE (2016)
   Low Circulating Levels of Mitochondrial and High Levels of Nuclear DNA Predict Mortality in Chronic Heart Failure
   J Card Fail, 22 (10), 823-8
   DOI 10.1016/j.cardfail.2016.06.013, PubMed 27349571
5. Gullestad L, Eiskjaer H, Gustafsson F, Riise GC, Karason K, Dellgren G, Rådegran G, Hansson L, Gude E, Bjørtuft Ø, Jansson K, Schultz HH, Solbu D, Iversen M (2016)
   Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial
   Transpl Int, 29 (7), 819-29
   DOI 10.1111/tri.12783, PubMed 27067532
6. Hussain AI, Garratt AM, Brunborg C, Aakhus S, Gullestad L, Pettersen KI (2016)
   Eliciting Patient Risk Willingness in Clinical Consultations as a Means of Improving Decision-Making of Aortic Valve Replacement
   J Am Heart Assoc, 5 (3), e002828
   DOI 10.1161/JAHA.115.002828, PubMed 26994130
7. Kleveland O, Kunszt G, Bratlie M, Ueland T, Broch K, Holte E, Michelsen AE, Bendz B, Amundsen BH, Espevik T, Aakhus S, Damås JK, Aukrust P, Wiseth R, Gullestad L (2016)
   Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
   Eur Heart J, 37 (30), 2406-13
   DOI 10.1093/eurheartj/ehw171, PubMed 27161611
8. Mirza K, Gustafsson F, Gullestad L, Arora S, Andersen C (2016)
   Effect of everolimus initiation and early calcineurin inhibitor withdrawal on myocardial FOXP3+ regulatory T cells in heart transplantation
   Transpl Immunol, 38, 75-7
   DOI 10.1016/j.trim.2016.05.004, PubMed 27260644
9. Munkhaugen J, Sverre E, Peersen K, Egge Ø, Gjertsen Eikeseth C, Gjertsen E, Gullestad L, Erik Otterstad J, Husebye E, Dammen T (2016)
   Patient characteristics and risk factors of participants and non-participants in the NOR-COR study
   Scand Cardiovasc J, 50 (5-6), 317-322
   DOI 10.1080/14017431.2016.1202445, PubMed 27323914
10. Murbraech K, Holte E, Broch K, Smeland KB, Holte H, Rösner A, Lund MB, Dalen H, Kiserud C, Aakhus S (2016)
    Impaired Right Ventricular Function in Long-Term Lymphoma Survivors
    J Am Soc Echocardiogr, 29 (6), 528-36
    DOI 10.1016/j.echo.2016.02.014, PubMed 27038515
11. Solberg OG, Stavem K, Ragnarsson A, Ioanes D, Arora S, Endresen K, Benth JŠ, Gullestad L, Gude E, Andreassen AK, Aaberge L (2016)
    Index of microvascular resistance after early conversion from calcineurin inhibitor to everolimus in heart transplantation: A sub-study to a 1-year randomized trial
    J Heart Lung Transplant, 35 (8), 1010-7
    DOI 10.1016/j.healun.2016.03.002, PubMed 27113960
12. Soubrier M, Pei J, Durand F, Gullestad L, John A (2016)
    Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis
    Rheumatol Ther, 4 (1), 133-149
    DOI 10.1007/s40744-016-0049-8, PubMed 27900570
13. Tegn N, Abdelnoor M, Aaberge L, Endresen K, Gullestad L, Bendz B (2016)
    [Not Available]
    Tidsskr Nor Laegeforen, 136 (16), 1324-5
    DOI 10.4045/tidsskr.16.0685, PubMed 27637033
14. Tegn N, Abdelnoor M, Aaberge L, Endresen K, Smith P, Aakhus S, Gjertsen E, Dahl-Hofseth O, Ranhoff AH, Gullestad L, Bendz B, After Eighty study investigators (2016)
    Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial
    Lancet, 387 (10023), 1057-1065
    DOI 10.1016/S0140-6736(15)01166-6, PubMed 26794722
15. Yardley M, Gullestad L, Bendz B, Bjørkelund E, Rolid K, Arora S, Nytrøen K (2016)
    Long-term effects of high-intensity interval training in heart transplant recipients: A 5-year follow-up study of a randomized controlled trial
    Clin Transplant, 31 (1)
    DOI 10.1111/ctr.12868, PubMed 27865004

Publications 2015

1. Arora S, Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Bøtker HE, Rådegran G, Gude E, Ioanes D, Solbu D, Sigurdardottir V, Dellgren G, Erikstad I, Solberg OG, Ueland T, Aukrust P, Gullestad L, SCHEDULE (SCandinavian HEart transplant everolimus De novo stUdy with earLy calcineurin inhibitors avoidancE) Investigators (2015)
   The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial
   Am J Transplant, 15 (7), 1967-75
   DOI 10.1111/ajt.13214, PubMed 25783974
2. Askevold ET, Gullestad L, Nymo S, Kjekshus J, Yndestad A, Latini R, Cleland JG, McMurray JJ, Aukrust P, Ueland T (2015)
   Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
   PLoS One, 10 (8), e0133970
   DOI 10.1371/journal.pone.0133970, PubMed 26288364
3. Baysa A, Sagave J, Carpi A, Zaglia T, Campesan M, Dahl CP, Bilbija D, Troitskaya M, Gullestad L, Giorgio M, Mongillo M, Di Lisa F, Vaage JI, Valen G (2015)
   The p66ShcA adaptor protein regulates healing after myocardial infarction
   Basic Res Cardiol, 110 (2), 13
   DOI 10.1007/s00395-015-0470-0, PubMed 25680868
4. Broch K, Andreassen AK, Hopp E, Leren TP, Scott H, Müller F, Aakhus S, Gullestad L (2015)
   Results of comprehensive diagnostic work-up in 'idiopathic' dilated cardiomyopathy
   Open Heart, 2 (1), e000271
   DOI 10.1136/openhrt-2015-000271, PubMed 26468400
5. Broch K, Murbraech K, Ragnarsson A, Gude E, Andersen R, Fiane AE, Andreassen J, Aakhus S, Andreassen AK (2015)
   Echocardiographic evidence of right ventricular functional improvement after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
   J Heart Lung Transplant, 35 (1), 80-86
   DOI 10.1016/j.healun.2015.08.007, PubMed 26476768
6. Broch K, Murbræch K, Andreassen AK, Hopp E, Aakhus S, Gullestad L (2015)
   Contemporary Outcome in Patients With Idiopathic Dilated Cardiomyopathy
   Am J Cardiol, 116 (6), 952-9
   DOI 10.1016/j.amjcard.2015.06.022, PubMed 26233575
7. Broch K, Urheim S, Lønnebakken MT, Stueflotten W, Massey R, Fosså K, Hopp E, Aakhus S, Gullestad L (2015)
   Controlled release metoprolol for aortic regurgitation: a randomised clinical trial
   Heart, 102 (3), 191-7
   DOI 10.1136/heartjnl-2015-308416, PubMed 26661319
8. Cowie MR, Woehrle H, Oldenburg O, Damy T, van der Meer P, Erdman E, Metra M, Zannad F, Trochu JN, Gullestad L, Fu M, Böhm M, Auricchio A, Levy P (2015)
   Sleep-disordered Breathing in Heart Failure - Current State of the Art
   Card Fail Rev, 1 (1), 16-24
   DOI 10.15420/cfr.2015.01.01.16, PubMed 28785426
9. De Blois J, Fagerland MW, Grundtvig M, Semb AG, Gullestad L, Westheim A, Hole T, Atar D, Agewall S (2015)
   ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry
   Eur Heart J Cardiovasc Pharmacother, 1 (1), 31-6
   DOI 10.1093/ehjcvp/pvu010, PubMed 27533962
10. Dhondup Y, Sjaastad I, Scott H, Sandanger Ø, Zhang L, Haugstad SB, Aronsen JM, Ranheim T, Holmen SD, Alfsnes K, Ahmed MS, Attramadal H, Gullestad L, Aukrust P, Christensen G, Yndestad A, Vinge LE (2015)
    Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice
    PLoS One, 10 (10), e0139715
    DOI 10.1371/journal.pone.0139715, PubMed 26461521
11. Estensen ME, Grindheim G, Remme EW, Godang K, Henriksen T, Aukrust P, Aakhus S, Gullestad L, Ueland T (2015)
    Elevated inflammatory markers in preeclamptic pregnancies, but no relation to systemic arterial stiffness
    Pregnancy Hypertens, 5 (4), 325-9
    DOI 10.1016/j.preghy.2015.09.003, PubMed 26597749
12. Fosshaug LE, Dahl CP, Risnes I, Bohov P, Berge RK, Nymo S, Geiran O, Yndestad A, Gullestad L, Aukrust P, Vinge LE, Øie E (2015)
    Altered Levels of Fatty Acids and Inflammatory and Metabolic Mediators in Epicardial Adipose Tissue in Patients With Systolic Heart Failure
    J Card Fail, 21 (11), 916-23
    DOI 10.1016/j.cardfail.2015.07.014, PubMed 26231517
13. Geir Solberg O, Aaberge L, Ragnarsson A, Aas M, Endresen K, Šaltytė Benth J, Gullestad L, Stavem K (2015)
    Comparison of simplified and comprehensive methods for assessing the index of microvascular resistance in heart transplant recipients
    Catheter Cardiovasc Interv, 87 (2), 283-90
    DOI 10.1002/ccd.26283, PubMed 26525162
14. Hussain AI, Garratt AM, Beitnes JO, Gullestad L, Pettersen KI (2015)
    Validity of standard gamble utilities in patients referred for aortic valve replacement
    Qual Life Res, 25 (7), 1703-12
    DOI 10.1007/s11136-015-1186-1, PubMed 26603737
15. Munkhaugen J, Sverre E, Peersen K, Gjertsen E, Gullestad L, Moum T, Otterstad JE, Perk J, Husebye E, Dammen T (2015)
    The role of medical and psychosocial factors for unfavourable coronary risk factor control
    Scand Cardiovasc J, 50 (1), 1-8
    DOI 10.3109/14017431.2015.1111408, PubMed 26488672
16. Norum HM, Gullestad L, Abraityte A, Broch K, Aakhus S, Aukrust P, Ueland T (2015)
    Increased Serum Levels of the Notch Ligand DLL1 are Associated with Diastolic Dysfunction, Reduced Exercise Capacity, and Adverse Outcome in Chronic Heart Failure
    J Card Fail, 22 (3), 218-23
    DOI 10.1016/j.cardfail.2015.07.012, PubMed 26211721
17. Nymo SH, Ueland T, Askevold E, Dahl CP, Gullestad L, Aukrust P, Yndestad A (2015)
    Circulating nucleosomes in chronic heart failure
    Int J Cardiol, 203, 742-3
    DOI 10.1016/j.ijcard.2015.10.219, PubMed 26595779
18. Nytrøen K, Yardley M, Rolid K, Bjørkelund E, Karason K, Wigh JP, Dall CH, Arora S, Aakhus S, Lunde K, Solberg OG, Gustafsson F, Prescott EI, Gullestad L (2015)
    Design and rationale of the HITTS randomized controlled trial: Effect of High-intensity Interval Training in de novo Heart Transplant Recipients in Scandinavia
    Am Heart J, 172, 96-105
    DOI 10.1016/j.ahj.2015.10.011, PubMed 26856221
19. Ofstad AP, Urheim S, Dalen H, Orvik E, Birkeland KI, Gullestad L, W Fagerland M, Johansen OE, Aakhus S (2015)
    Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls
    J Diabetes, 7 (6), 779-90
    DOI 10.1111/1753-0407.12239, PubMed 25350248
20. Røysland R, Røsjø H, Høiseth AD, Gullestad L, Badr P, Kravdal G, Omland T (2015)
    Osteoprotegerin concentrations in patients with suspected reversible myocardial ischemia: observations from the Akershus Cardiac Examination (ACE) 1 Study
    Cytokine, 73 (1), 122-7
    DOI 10.1016/j.cyto.2015.01.020, PubMed 25748834
21. Schurgers LJ, Burgmaier M, Ueland T, Schutters K, Aakhus S, Hofstra L, Gullestad L, Aukrust P, Hellmich M, Narula J, Reutelingsperger CP (2015)
    Circulating annexin A5 predicts mortality in patients with heart failure
    J Intern Med, 279 (1), 89-97
    DOI 10.1111/joim.12396, PubMed 26223343
22. Ulimoen GR, Ofstad AP, Endresen K, Gullestad L, Johansen OE, Borthne A (2015)
    Low-dose CT coronary angiography for assessment of coronary artery disease in patients with type 2 diabetes--a cross-sectional study
    BMC Cardiovasc Disord, 15, 147
    DOI 10.1186/s12872-015-0143-9, PubMed 26573616
23. Yardley M, Havik OE, Grov I, Relbo A, Gullestad L, Nytrøen K (2015)
    Peak oxygen uptake and self-reported physical health are strong predictors of long-term survival after heart transplantation
    Clin Transplant, 30 (2), 161-9
    DOI 10.1111/ctr.12672, PubMed 26589579

Publications 2014

1. Abraityte A, Gullestad L, Askevold ET, Nymo S, Dahl CP, Aakhus S, Aukrust P, Ueland T (2014)
   The Notch ligand Delta-like 1 is elevated and associated with mortality in patients with symptomatic aortic stenosis
   Int J Cardiol, 180, 18-20
   DOI 10.1016/j.ijcard.2014.11.111, PubMed 25438200
2. Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Radegran G, Gude E, Jansson K, Solbu D, Sigurdardottir V, Arora S, Dellgren G, Gullestad L, SCHEDULE Investigators (2014)
   Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial
   Am J Transplant, 14 (8), 1828-38
   DOI 10.1111/ajt.12809, PubMed 25041227
3. Apelland T, Gude E, Strøm EH, Gullestad L, Eiklid KL, Månsson JE, Reinholt FP, Houge G, Dahl CP, Almaas VM, Heiberg A (2014)
   Familial globotriaosylceramide-associated cardiomyopathy mimicking Fabry disease
   Heart, 100 (22), 1793-8
   DOI 10.1136/heartjnl-2014-305616, PubMed 25031264
4. Arora S, Gullestad L (2014)
   The challenge of allograft vasculopathy in cardiac transplantation
   Curr Opin Organ Transplant, 19 (5), 508-14
   DOI 10.1097/MOT.0000000000000112, PubMed 25144667
5. Askevold ET, Aukrust P, Nymo SH, Lunde IG, Kaasbøll OJ, Aakhus S, Florholmen G, Ohm IK, Strand ME, Attramadal H, Fiane A, Dahl CP, Finsen AV, Vinge LE, Christensen G, Yndestad A, Gullestad L, Latini R, Masson S, Tavazzi L, GISSI-HF Investigators, Ueland T (2014)
   The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure
   J Intern Med, 275 (6), 621-30
   DOI 10.1111/joim.12175, PubMed 24330105
6. Askevold ET, Gullestad L, Dahl CP, Yndestad A, Ueland T, Aukrust P (2014)
   Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure
   Curr Heart Fail Rep, 11 (2), 146-55
   DOI 10.1007/s11897-014-0185-9, PubMed 24477903
7. Bilbija D, Elmabsout AA, Sagave J, Haugen F, Bastani N, Dahl CP, Gullestad L, Sirsjö A, Blomhoff R, Valen G (2014)
   Expression of retinoic acid target genes in coronary artery disease
   Int J Mol Med, 33 (3), 677-86
   DOI 10.3892/ijmm.2014.1623, PubMed 24424466
8. Bot I, Daissormont IT, Zernecke A, van Puijvelde GH, Kramp B, de Jager SC, Sluimer JC, Manca M, Hérias V, Westra MM, Bot M, van Santbrink PJ, van Berkel TJ, Su L, Skjelland M, Gullestad L, Kuiper J, Halvorsen B, Aukrust P, Koenen RR, Weber C, Biessen EA (2014)
   CXCR4 blockade induces atherosclerosis by affecting neutrophil function
   J Mol Cell Cardiol, 74, 44-52
   DOI 10.1016/j.yjmcc.2014.04.021, PubMed 24816217
9. Broch K, Al-Ani A, Gude E, Gullestad L, Aakhus S (2014)
   Echocardiographic evaluation of left ventricular filling pressure in heart transplant recipients
   Scand Cardiovasc J, 48 (6), 349-56
   DOI 10.3109/14017431.2014.981579, PubMed 25414078
10. Broch K, Andreassen AK, Ueland T, Michelsen AE, Stueflotten W, Aukrust P, Aakhus S, Gullestad L (2014)
    Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure
    Int J Cardiol, 179, 378-84
    DOI 10.1016/j.ijcard.2014.11.003, PubMed 25464491
11. Broch K, Askevold ET, Gjertsen E, Ueland T, Yndestad A, Godang K, Stueflotten W, Andreassen J, Svendsmark R, Smith HJ, Aakhus S, Aukrust P, Gullestad L (2014)
    The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial
    PLoS One, 9 (2), e89732
    DOI 10.1371/journal.pone.0089732, PubMed 24586994
12. Cornu C, Dufays C, Gaillard S, Gueyffier F, Redonnet M, Sebbag L, Roussoulières A, Gleissner CA, Groetzner J, Lehmkuhl HB, Potena L, Gullestad L, Cantarovich M, Boissonnat P (2014)
    Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysis
    Br J Clin Pharmacol, 78 (1), 24-32
    DOI 10.1111/bcp.12289, PubMed 24251918
13. Finsen AV, Ueland T, Sjaastad I, Ranheim T, Ahmed MS, Dahl CP, Askevold ET, Aakhus S, Husberg C, Fiane AE, Lipp M, Gullestad L, Christensen G, Aukrust P, Yndestad A (2014)
    The homeostatic chemokine CCL21 predicts mortality in aortic stenosis patients and modulates left ventricular remodeling
    PLoS One, 9 (11), e112172
    DOI 10.1371/journal.pone.0112172, PubMed 25398010
14. Gustafsson F, Gude E, Sigurdardottir V, Aukrust P, Solbu D, Goetze JP, Gullestad L (2014)
    Plasma NGAL and glomerular filtration rate in cardiac transplant recipients treated with standard or reduced calcineurin inhibitor levels
    Biomark Med, 8 (2), 239-45
    DOI 10.2217/bmm.13.95, PubMed 24521021
15. Halvorsen B, Smedbakken LM, Michelsen AE, Skjelland M, Bjerkeli V, Sagen EL, Taskén K, Bendz B, Gullestad L, Holm S, Biessen EA, Aukrust P (2014)
    Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13
    Atherosclerosis, 234 (2), 352-9
    DOI 10.1016/j.atherosclerosis.2014.03.021, PubMed 24732574
16. Hasselberg NE, Haugaa KH, Sarvari SI, Gullestad L, Andreassen AK, Smiseth OA, Edvardsen T (2014)
    Left ventricular global longitudinal strain is associated with exercise capacity in failing hearts with preserved and reduced ejection fraction
    Eur Heart J Cardiovasc Imaging, 16 (2), 217-24
    DOI 10.1093/ehjci/jeu277, PubMed 25552469
17. Holm T, Færestrand S, Larsen AI, Jønland KB, Gullestad L, Dickstein K, Köpp U, Sirnes PA, Tande P, Steen T, Kongsgård E (2014)
    [Cardiac resynchronization therapy in heart failure--Norwegian guidelines]
    Tidsskr Nor Laegeforen, 134 (10), E1-17
    DOI 10.4045/tidsskr.13.0628, PubMed 24865746
18. Ofstad AP, Johansen OE, Gullestad L, Birkeland KI, Orvik E, Fagerland MW, Urheim S, Aakhus S (2014)
    Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi-intervention in type 2 diabetes: the randomized controlled Asker and Bærum Cardiovascular Diabetes (ABCD) study
    Am Heart J, 168 (3), 280-288.e2
    DOI 10.1016/j.ahj.2014.03.026, PubMed 25173538
19. Perez-Moreno AC, Jhund PS, Macdonald MR, Petrie MC, Cleland JG, Böhm M, van Veldhuisen DJ, Gullestad L, Wikstrand J, Kjekshus J, Lewsey JD, McMurray JJ (2014)
    Fatigue as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)
    JACC Heart Fail, 2 (2), 187-97
    DOI 10.1016/j.jchf.2014.01.001, PubMed 24720928
20. Perez AC, Jhund PS, Stott DJ, Gullestad L, Cleland JG, van Veldhuisen DJ, Wikstrand J, Kjekshus J, McMurray JJ (2014)
    Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure)
    JACC Heart Fail, 2 (1), 35-40
    DOI 10.1016/j.jchf.2013.07.008, PubMed 24622117
21. Rogers JK, Jhund PS, Perez AC, Böhm M, Cleland JG, Gullestad L, Kjekshus J, van Veldhuisen DJ, Wikstrand J, Wedel H, McMurray JJ, Pocock SJ (2014)
    Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)
    JACC Heart Fail, 2 (3), 289-97
    DOI 10.1016/j.jchf.2013.12.007, PubMed 24952697
22. Solberg OG, Ragnarsson A, Kvarsnes A, Endresen K, Kongsgard E, Aakhus S, Gullestad L, Stavem K, Aaberge L (2014)
    Reference interval for the index of coronary microvascular resistance
    EuroIntervention, 9 (9), 69-75
    DOI 10.4244/EIJV919A181
23. Solberg OG, Ragnarsson A, Kvarsnes A, Endresen K, Kongsgård E, Aakhus S, Gullestad L, Stavem K, Aaberge L (2014)
    Reference interval for the index of coronary microvascular resistance
    EuroIntervention, 9 (9), 1069-75
    DOI 10.4244/EIJV9I9A181, PubMed 24457279
24. Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, Aakhus S, Gude E, Bjørndal B, Halvorsen B, Karlsen TH, Aukrust P, Gullestad L, Berge RK, Yndestad A (2014)
    Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure
    J Intern Med, 277 (6), 717-26
    DOI 10.1111/joim.12328, PubMed 25382824
25. Ueland T, Aukrust P, Nymo SH, Kjekshus J, McMurray JJ, Wikstrand J, Block D, Zaugg C, Gullestad L (2014)
    Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial
    J Card Fail, 21 (2), 153-9
    DOI 10.1016/j.cardfail.2014.10.016, PubMed 25451704
26. Ueland T, Aukrust P, Nymo SH, Kjekshus J, McMurray JJ, Wikstrand J, Wienhues-Thelen UH, Block D, Zaugg C, Gullestad L (2014)
    Predictive value of endostatin in chronic heart failure patients with poor kidney function
    Cardiology, 130 (1), 17-22
    DOI 10.1159/000368220, PubMed 25428583
27. Ueland T, Gullestad L, Nymo SH, Yndestad A, Aukrust P, Askevold ET (2014)
    Inflammatory cytokines as biomarkers in heart failure
    Clin Chim Acta, 443, 71-7
    DOI 10.1016/j.cca.2014.09.001, PubMed 25199849
28. Wu X, Sagave J, Rutkovskiy A, Haugen F, Baysa A, Nygård S, Czibik G, Dahl CP, Gullestad L, Vaage J, Valen G (2014)
    Expression of bone morphogenetic protein 4 and its receptors in the remodeling heart
    Life Sci, 97 (2), 145-54
    DOI 10.1016/j.lfs.2013.12.030, PubMed 24398041

Publications 2013

1. Dahl CP, Aukrust P, Nymo SH, Kjekshus J, Cleland JG, McMurray JJ, Wikstrand J, Gullestad L, Ueland T (2013)
   Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure
   Int J Cardiol, 168 (4), 4427-9
   DOI 10.1016/j.ijcard.2013.05.008, PubMed 23714594
2. Doenst T, Cleland JG, Rouleau JL, She L, Wos S, Ohman EM, Krzeminska-Pakula M, Airan B, Jones RH, Siepe M, Sopko G, Velazquez EJ, Racine N, Gullestad L, Filgueira JL, Lee KL, STICH Investigators (2013)
   Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease
   Circ Heart Fail, 6 (3), 443-50
   DOI 10.1161/CIRCHEARTFAILURE.112.000130, PubMed 23515275
3. Gravning J, Askevold ET, Nymo SH, Ueland T, Wikstrand J, McMurray JJ, Aukrust P, Gullestad L, Kjekshus J, CORONA Study Group (2013)
   Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial
   Circ Heart Fail, 7 (1), 96-103
   DOI 10.1161/CIRCHEARTFAILURE.113.000450, PubMed 24284025
4. Gregersen I, Skjelland M, Holm S, Holven KB, Krogh-Sørensen K, Russell D, Askevold ET, Dahl CP, Ørn S, Gullestad L, Mollnes TE, Ueland T, Aukrust P, Halvorsen B (2013)
   Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis
   PLoS One, 8 (8), e72769
   DOI 10.1371/journal.pone.0072769, PubMed 24023645
5. Karlson BW, Dellborg M, Gullestad L, Aberg J, Sugg J, Herlitz J (2013)
   A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label study
   Cardiology, 127 (2), 73-82
   DOI 10.1159/000355003, PubMed 24247812
6. Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors AA, Nielsen OW, Zannad F, Tavazzi L, Heart Failure Association of the European Society of Cardiology (HFA) (2013)
   EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
   Eur J Heart Fail, 15 (7), 808-17
   DOI 10.1093/eurjhf/hft050, PubMed 23537547
7. Nymo SH, Hulthe J, Ueland T, McMurray J, Wikstrand J, Askevold ET, Yndestad A, Gullestad L, Aukrust P (2013)
   Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA
   Eur J Heart Fail, 16 (1), 68-75
   DOI 10.1093/eurjhf/hft125, PubMed 23918775
8. Nytrøen K, Gullestad L (2013)
   Effect of exercise in heart transplant recipients
   Am J Transplant, 13 (2), 527
   DOI 10.1111/ajt.12046, PubMed 23356900
9. Nytrøen K, Gullestad L (2013)
   [Exercise after heart transplantation--old principles needs reevaluation]
   Tidsskr Nor Laegeforen, 133 (19), 2030-1
   DOI 10.4045/tidsskr.13.0903, PubMed 24129530
10. Nytrøen K, Gullestad L (2013)
    Exercise after heart transplantation: An overview
    World J Transplant, 3 (4), 78-90
    DOI 10.5500/wjt.v3.i4.78, PubMed 24392312
11. Nytrøen K, Rustad LA, Erikstad I, Aukrust P, Ueland T, Lekva T, Gude E, Wilhelmsen N, Hervold A, Aakhus S, Gullestad L, Arora S (2013)
    Effect of high-intensity interval training on progression of cardiac allograft vasculopathy
    J Heart Lung Transplant, 32 (11), 1073-80
    DOI 10.1016/j.healun.2013.06.023, PubMed 23906899
12. Ofstad AP, Gullestad L, Orvik E, Aakhus S, Endresen K, Ueland T, Aukrust P, Fagerland MW, Birkeland KI, Johansen OE (2013)
    Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study
    Cardiovasc Diabetol, 12, 126
    DOI 10.1186/1475-2840-12-126, PubMed 23987834
13. Prohászka Z, Munthe-Fog L, Ueland T, Gombos T, Yndestad A, Förhécz Z, Skjoedt MO, Pozsonyi Z, Gustavsen A, Jánoskuti L, Karádi I, Gullestad L, Dahl CP, Askevold ET, Füst G, Aukrust P, Mollnes TE, Garred P (2013)
    Association of ficolin-3 with severity and outcome of chronic heart failure
    PLoS One, 8 (4), e60976
    DOI 10.1371/journal.pone.0060976, PubMed 23596511
14. Robertsen I, Falck P, Andreassen AK, Næss NK, Lunder N, Christensen H, Gullestad L, Asberg A (2013)
    Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients
    Transplant Res, 2 (1), 5
    DOI 10.1186/2047-1440-2-5, PubMed 23566530
15. Rustad LA, Nytrøen K, Andreassen A, Geiran O, Endresen K, Gullestad L, Aakhus S, Amundsen BH (2013)
    Heart transplant systolic and diastolic function is impaired by prolonged pretransplant graft ischaemic time and high donor age: an echocardiographic study
    Eur J Cardiothorac Surg, 44 (2), e97-104
    DOI 10.1093/ejcts/ezt233, PubMed 23657552
16. Strand ME, Herum KM, Rana ZA, Skrbic B, Askevold ET, Dahl CP, Vistnes M, Hasic A, Kvaløy H, Sjaastad I, Carlson CR, Tønnessen T, Gullestad L, Christensen G, Lunde IG (2013)
    Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart
    FEBS J, 280 (10), 2228-47
    DOI 10.1111/febs.12161, PubMed 23374111
17. Ueland T, Nymo SH, Latini R, McMurray JJ, Kjekshus J, Yndestad A, Fucili A, Grosu A, Masson S, Maggioni AP, Gullestad L, Aukrust P, Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) trial, Investigators of the GISSI-Heart Failure (GISSI-HF) trial (2013)
    CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials
    Eur J Heart Fail, 15 (7), 747-55
    DOI 10.1093/eurjhf/hft031, PubMed 23487539
18. van der Velde AR, Gullestad L, Ueland T, Aukrust P, Guo Y, Adourian A, Muntendam P, van Veldhuisen DJ, de Boer RA (2013)
    Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH
    Circ Heart Fail, 6 (2), 219-26
    DOI 10.1161/CIRCHEARTFAILURE.112.000129, PubMed 23395934